SUMMARY Six patients with hemifacial spasm were treated with injections of botulinum toxin A into the orbicularis oculi; the abnormal movements around the eye were relieved for an average of 15 weeks. There were no systemic or significant local side effects, and in view of the risks involved in neurosurgical treatment, a trial of botulinum toxin injections is recommended in the first instance in this condition.
Idiopathic hemifacial spasm consists of irregular, unilateral clonic twitching or more sustained contractions of the facial muscles. Of insidious onset in the 5th or 6th decades, affecting females more than males, it often starts in the orbicularis oculi and progresses in a stereotyped way, to involve all the facial muscles, including the platysma. A mild facial weakness may develop, but facial sensation is normal, and there are no other neurological signs.2 The spasms are a social and psychological problem, and may also be uncomfortable, but are only of functional significance if vision is poor in the contralateral eye.
Hemifacial spasm persists during sleep, is unaffected by a stroke and recurs following distal seventh nerve section when the nerve regenerates3: all these features suggest that a disturbance of either the facial nucleus or the facial nerve proximal to the stylomastoid foramen is responsible. Electrophysiological angiography is normal in these cases, and the evidence is based on the findings at retromastoid craniectomy, and the relief of symptoms when a sponge is interposed between the abnormal vessel and the nerve. The electrophysiological findings revert to normal after this procedure.8 1' It is a safe operation, but although up to 87 5% of patients have an excellent or good result,'6 the recurrence rate may be up to 25% over the next two years'6 and up to 25% " of patients suffer permanent unilateral deafness or facial palsy.
The neurovascular relations at the facial nerve root exit zone are complex, and anomalies are commonly found at necropsy.'8 Only four out of 16 patients in one series were thought to have a vascular abnormality at operation, but 14 were relieved of spasm by wrapping a sponge around the nerve.'9 In all operative series, the spasms often take several months to resolve, and it may be that either the operative manipulation of the nerve, or subsequent fibrosis in relation to the sponge is responsible.'5 Alternative forms of treatment, however, are not often helpful. Drugs usually have no influence, although carbamazepine may be useful.20 Partial peripheral nerve section distal to the stylomastoid foramen,3 selective neurectomy2l or thermocoagulation22 are complicated by facial weakness and recurrence of the spasm. Transtympanic facial nerve needling has the same problems. Following experience with injections of botulinum toxin A in the Botulinum toxin A (1 5 ,ug) was injected in 1 ml saline in four divided doses into the orbicularis oculi as previously described.22 Two weeks later, in cases 2 and 4, a further 0 4 ng toxin was injected into the buccolabial musculature on the same side. Follow up thereafter was at monthly intervals, or at any stage if the spasms around the eye recurred.
Results
The abnormal movements around the eyes were relieved in all patients within 3 or 4 days after the injection. As the spasms resolved, tissue fluid tended to accumulate in the eyelids, but a true ptosis, caused by spread of the toxin to the levator palpebrae superioris only occurred in cases 1 and 3 after the first injection. It was mild and resolved over two weeks, and there were no systemic side effects. Injection of the buccolabial musculature in cases 2 and 4 relieved the lower facial spasms, but caused a mild temporary facial weakness, which resolved over 10 to 12 weeks.
The spasms around the eye began to return gradually after between 12 and 20 weeks ( Paralysing the orbicularis oculi with botulinum toxin A is a simple, cheap and effective outpatient treatment that has no systemic side effects, and local side effects resolve rapidly. Although it is possible to paralyse selectively any of the muscles involved in the spasms, extending the injections away from the eye produced a mild facial weakness. The major symptoms in hemifacial spasm, however, are due to spasmodic eye closure, and abolishing this alone relieved discomfort and provided cosmetic improvement in all patients. With 
